taurocholic acid has been researched along with Benign Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreyev, HJN; Gee, C; Jackson, A; Kabir, M; Lalji, A; Muls, A; Shaw, C; Vyoral, S | 1 |
| Cho, KJ; Khatun, Z; Lee, YK; Nurunnabi, M; Reeck, GR | 1 |
| Al-Hilal, TA; Alam, F; Byun, Y; Chung, SW; Kim, HS; Kim, SY; Mahmud, F; Seo, D | 1 |
| Byun, Y; Chung, SW; Han, J; Kim, JY; Lee, S; Oh, YK; Shim, G | 1 |
| Chu, L; Han, X; Zhai, G; Zhang, H; Zhao, L | 1 |
| Al-Hilal, TA; Alam, F; Byun, Y; Chung, SW; Kim, HS; Lee, DS; Mahmud, F; Park, J; Seo, D | 1 |
| Al-Hilal, TA; Bae, SM; Byun, Y; Chung, SW; Kim, IS; Kim, JK; Kim, SY; Lee, CK; Lee, M | 1 |
| Bullock, K; Cheng, S; Clish, CB; Deik, AA; Gerszten, RE; Ghorbani, A; Ho, JE; Jacques, PF; Larson, MG; Magnusson, M; McCabe, EL; Melander, O; Murabito, JM; O'Donnell, CJ; Pierce, KA; Rhee, EP; Souza, AL; Vasan, RS; Wang, TJ | 1 |
| Byun, Y; Choi, HW; Chung, SW; Kim, CW; Kim, JY; Kim, K; Kim, S; Kim, SY; Kwon, IC; Oh, YK; Park, J; Shim, G; Yang, VC | 1 |
9 other study(ies) available for taurocholic acid and Benign Neoplasms
| Article | Year |
|---|---|
The efficacy of a low-fat diet to manage the symptoms of bile acid malabsorption - outcomes in patients previously treated for cancer.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Diarrhea; Diet, Fat-Restricted; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Steatorrhea; Taurocholic Acid; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2017 |
Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Delivery Systems; Female; Heparin, Low-Molecular-Weight; Humans; Mice; Mice, Nude; Neoplasms; Taurocholic Acid; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biological Availability; Caco-2 Cells; Cell Proliferation; Deoxycholic Acid; Heparin; Heparin, Low-Molecular-Weight; Human Umbilical Vein Endothelial Cells; Humans; Intestinal Absorption; Intestines; Male; Neoplasms; Neovascularization, Physiologic; Oxidation-Reduction; Rats, Sprague-Dawley; Spheroids, Cellular; Taurocholic Acid | 2014 |
Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
Topics: Adsorption; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Stability; Female; Graphite; Heparin, Low-Molecular-Weight; Humans; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Oxidation-Reduction; Taurocholic Acid; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Preparation, optimization, characterization and cytotoxicity in vitro of Baicalin-loaded mixed micelles.
Topics: Antineoplastic Agents; Cell Survival; Delayed-Action Preparations; Flavonoids; Hep G2 Cells; Humans; Micelles; Neoplasms; Poloxalene; Taurocholic Acid | 2014 |
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Heparin, Low-Molecular-Weight; Humans; Male; Mice, Inbred C3H; Mice, Nude; Nanostructures; Neoplasms; Neovascularization, Pathologic; Polyethylene Glycols; Protamines; Rats, Sprague-Dawley; Taurocholic Acid; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Cell Line; Chemotaxis; Coculture Techniques; Collagen; Contrast Media; Drug Combinations; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Heparin, Low-Molecular-Weight; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; Laminin; Magnetic Resonance Imaging; Male; Mice, Inbred BALB C; Neoplasms; Neovascularization, Pathologic; Pericytes; Proteoglycans; Proto-Oncogene Proteins c-sis; Signal Transduction; Taurocholic Acid; Vascular Endothelial Growth Factor A | 2015 |
Distinct metabolomic signatures are associated with longevity in humans.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Female; Humans; Isocitrates; Longevity; Longitudinal Studies; Male; Mass Spectrometry; Metabolome; Middle Aged; Neoplasms; Odds Ratio; Prognosis; Survival Analysis; Taurocholic Acid | 2015 |
Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.
Topics: Animals; Antineoplastic Agents; Cations; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Electrophoretic Mobility Shift Assay; Heparin; Hydroxamic Acids; Injections, Intravenous; Liposomes; Mice; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Serum; Taurocholic Acid; Time Factors; Tissue Distribution; Vorinostat | 2012 |